Linobo, Rosita D.
HRN: 27-22-61 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/01/2025
CEFTRIAXONE 1G (VIAL)
06/01/2025
06/08/2025
IV
2g
OD
Tbi Severe
Checking Initial Appropriateness